Focus issue: TGF-β and the mesenchymal transition in physiology and disease

Science Signaling

Volumn 7, Issue 345, 2014, Pages eg3-

  Ferrarelli, Leslie K ^a   Gough, Nancy R ^a  

^a AAAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN; PROTEIN P53; PROTEIN P63; PROTEIN P73; PROTEIN TYROSINE KINASE; SCLEROPROTEIN; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

BEHAVIOR; BLOOD VESSEL GRAFT; BREAST TUMOR; CANCER CELL LINE; CANCER GROWTH; CELL FUNCTION; CELL NUCLEUS MEMBRANE; CELL POPULATION; CELL PROLIFERATION; CELL STIMULATION; CELL STRUCTURE; DISEASE COURSE; DNA REPAIR; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FEEDBACK SYSTEM; FIBROSIS; GENE EXPRESSION; HUMAN; KERATINOCYTE; KIDNEY FIBROSIS; MESENCHYME CELL; METASTASIS POTENTIAL; NEOPLASM; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC SCLEROSIS; TISSUE INJURY; TISSUE REPAIR; TRANSPORT VESICLE; TRIPLE NEGATIVE BREAST CANCER; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; ANIMAL; METABOLISM; PHENOTYPE; PHYSIOLOGY;

ANIMALS; EMBRYONIC DEVELOPMENT; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; PHENOTYPE; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84907867527     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2005909     Document Type: Review

References (18)

1. P.-Y. Chen, L. Qin, G. Tellides, M. Simons, Fibroblast growth factor receptor 1 is a key inhibitor of TGFâ signaling in the endothelium. Sci. Signal. 7, ra90 (2014).
2. S. Svegliati, G. Marrone, A. Pezone, T. Spadoni, A. Grieco, G. Moroncini, D. Grieco, M. Vinciguerra, S. Agnese, A. Jüngel, O. Distler, A. M. Musti, A. Gabrielli, E.-V. Avvedimento, Oxidative DNA damage induces the ATM-mediated transcriptional suppression of the Wnt inhibitor WIF-1 in systemic sclerosis and fi brosis. Sci. Signal. 7, ra84 (2014).
3. J. Zhang, X.-J. Tian, H. Zhang, Y. Teng, R. Li, F. Bai, S. Elankumaran, J. Xing, TGF-α-induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops. Sci. Signal. 7, ra91 (2014).
4. M. H. Barcellos-Hoff, F. A. Cucinotta, New tricks for an old fox: Impact of TGFâ on the DNA damage response and genomic stability. Sci. Signal. 7, re5 (2014).
5. D. Engelmann, B. M. Pützer, Emerging from the shade of p53 mutants: N-terminally truncated variants of the p53 family in EMT signaling and cancer progression. Sci. Signal. 7, re9 (2014).
6. D. M. Gonzalez, D. Medici, Signaling mechanisms of the epithelial-mesenchymal transition. Sci. Signal. 7, re8 (2014).
7. P. Vizán, D. S. J. Miller, B. Schmierer, C. S. Hill, Response to "Comment on 'Controlling long-term signaling: Receptor dynamics determine attenuation and refractory behavior of the TGF-α pathway'- Smad2/3 activity does not predict the dynamics of transcription." Sci. Signal. 7, lc2 (2014).
8. A. Warmfl ash, Q. Zhang, A. H. Brivanlou, E. D. Siggia, Comment on "Controlling long-term signaling: Receptor dynamics determine attenuation and refractory behavior of the TGF-α pathway"- Smad2/3 activity does not predict the dynamics of transcription. Sci. Signal. 7, lc1 (2014).
9. M. Simons, A. M. VanHook, Science Signaling Podcast: 23 September 2014. Sci. Signal. 7, pc26 (2014).
10. B. Bourgeois, B. Gilquin, C. Tellier- Lebègue, C. Östlund, W. Wu, J. Pérez, P. El Hage, F. Lallemand, H. J. Worman, S. Zinn-Justin, Inhibition of TGF-α signaling at the nuclear envelope: Characterization of interactions between MAN1, Smad2 and Smad3, and PPM1A. Sci. Signal. 6, ra49 (2013).
11. S. K. Gudey, R. Sundar, Y. Mu, A. Wallenius, G. Zang, A. Bergh, C.-H. Heldin, M. Landström, TRAF6 stimulates the tumor-promoting effects of TGFâ type I receptor through polyubiquitination and activation of presenilin 1. Sci. Signal. 7, ra2 (2014).
12. M. Kato, V. Dang, M. Wang, J. T. Park, S. Deshpande, S. Kadam, A. Mardiros, Y. Zhan, P. Oettgen, S. Putta, H. Yuan, L. Lanting, R. Natarajan, TGF-α induces acetylation of chromatin and of Ets-1 to alleviate repression of miR-192 in diabetic nephropathy. Sci. Signal. 6, ra43 (2013).
13. H. H. Truong, J. Xiong, V. P. S. Ghotra, E. Nirmala, L. Haazen, S.-E. Le Dévédec, H. E. Balcioglu, S. He, B. E. Snaar- Jagalska, E. Vreugdenhil, J. H. N. Meerman, B. van de Water, E. H. J. Danen, â1 integrin inhibition elicits a prometastatic switch through the TGFâ-miR-200- ZEB network in E-cadherin-positive triple-negative breast cancer. Sci. Signal. 7, ra15 (2014).
14. P. Vizán, D. S. J. Miller, I. Gori, D. Das, B. Schmierer, C. S. Hill, Controlling long-term signaling: Receptor dynamics determine attenuation and refractory behavior of the TGF-α pathway. Sci. Signal. 6, ra106 (2013).
15. R. C. J. D'Souza, A. M. Knittle, N. Nagaraj, M. van Dinther, C. Choudhary, P. ten Dijke, M. Mann, K. Sharma, Timeresolved dissection of early phosphoproteome and ensuing proteome changes in response to TGF-α. Sci. Signal. 7, rs5 (2014).
16. Z. Dong, Acetylation of Ets-1 is the key to chromatin remodeling for miR-192 expression. Sci. Signal. 6, pe21 (2013).
17. A. Madamanchi, A. Zijlstra, M. M. Zutter, Flipping the switch: Integrin switching provides metastatic competence. Sci. Signal. 7, pe9 (2014).
18. E. H. J. Danen, A. M. VanHook, Science Signaling Podcast: 11 February 2014. Sci. Signal. 7, pc5 (2014).